A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

The purpose of this study is to determine if Dimebon is safe and effective for the treatment of cognitive impairment in Huntington disease.

Phase 3

Medivation, Inc.

Pfizer